DCEG- Genotyping for epidemiology studies

NIH RePORTER · NIH · N01 · $19,368,867 · view on reporter.nih.gov ↗

Abstract

The Cancer Genomics Research (CGR) Laboratory was established to investigate the contribution of genetic variation to cancer susceptibility and outcomes. Working in concert with epidemiologists, biostatisticians, and basic research scientists in DCEG’s intramural research program, the CGR provides the capacity to conduct genome-wide discovery studies and targeted regional approaches to identify the heritable determinants of various forms of cancer. New work has begun in somatic research with the use of tumor/normal tissue nucleic acids for cross-platform comparisons in subjects of interest. A support group for molecular and digital pathology research within CGR has been added to support these efforts. CGR supports DCEG in all stages of cancer research from planning to publishing, including experimental design and project management, sample handling, genotyping and sequencing assay design and execution, tissue research support, development and implementation of bioinformatic pipelines, and downstream research and analytical support. These factors make CGR a unique collaborative center for NCI-driven scientific endeavors.

Key facts

NIH application ID
10658786
Project number
75N91019D00024-P00018-759102000003-3
Recipient
LEIDOS BIOMEDICAL RESEARCH, INC.
Principal Investigator
LEONARD FREEDMAN
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$19,368,867
Award type
Project period
2020-08-31 → 2022-08-30